We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The 2024 GOLD report newly highlights hyperinflation, ...
Theory-based smoking cessation interventions helped to motivate patients with chronic obstructive pulmonary disease (COPD) who smoke to quit, ultimately improving their quality of life and lung ...
Researchers noted that the relationships between smoking, chronic obstructive pulmonary disease (COPD), and depression must be recognized to effectively manage the complicated care needs for this ...
In a population spirometric screening of 11,027 subjects who were at risk for COPD in 12 Polish cities, AL was detected in 30.6% of smokers who were > 39 years of age who had a smoking history of > 10 ...
Cytisinicline significantly increases quit rates in smokers with or without COPD while being safe and well tolerated.
If you start to experience symptoms like chest pain, blue lips, or coughing up more than a teaspoon of blood, you should see ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Immediately ...
Emphysema is an incurable, progressive lung condition that is a type of COPD. Quitting smoking can help prevent further lung deterioration in any stage of COPD and may also help slow progression.
Credit: Scott Bodell/MedicalImages.com The authors outline preventative pharmacologic therapies for COPD exacerbations and a patient-tailored approach to management. Chronic obstructive pulmonary ...
—A recent Australian study sought to determine the impact of COPD and smoking on post-operative pulmonary complications following lung cancer resection. Reviewed by Ware Kuschner, MD, Professor of ...
The underdiagnosed and poor management of COPD exacerbations represents a missed opportunity to prevent patient deterioration through proactive treatment approaches. Chronic obstructive pulmonary ...
SEATTLE/VANCOUVER - Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company with a market capitalization of $144 million, announced Monday that cytisinicline significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results